• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-2中的一个点突变,该突变改变了配体内化。

A point mutation in interleukin-2 that alters ligand internalization.

作者信息

Chang D Z, Wu Z, Ciardelli T L

机构信息

Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755-3835, USA.

出版信息

J Biol Chem. 1996 Jun 7;271(23):13349-55. doi: 10.1074/jbc.271.23.13349.

DOI:10.1074/jbc.271.23.13349
PMID:8662876
Abstract

In previous studies, we have identified an interleukin-2 (IL-2) analog containing a point mutation at position 51 (T51P) that expresses nearly wild-type bioactivity, yet has approximately 10-fold lower receptor binding affinity. Since ligand-dependent receptor internalization may be the rate-limiting step controlling the duration of IL-2 receptor signaling, a reduction in the receptor internalization rate could contribute to the observed response enhancement for this analog. To evaluate this possibility, we compared the internalization of IL-2 and T51P in three separate assays. While the internalization rate for IL-2 agreed with values determined by others, the internalization of T51P was markedly reduced. The receptor binding rate constants for this analog were only slightly different; thus, altered binding kinetics could not explain the decreased internalization rate. The effects of reduced internalization were also observable in bioassays, where T51P maintained T-cell proliferation for a longer period compared with IL-2. These results indicate that the T51P point mutation reduces the receptor internalization rate compared with IL-2 in a fashion that is independent of the dissociation rate. This analog may represent a new approach to the preparation of cytokine analogs with potentiated agonist and antagonist properties.

摘要

在先前的研究中,我们鉴定出一种白细胞介素-2(IL-2)类似物,其在第51位存在一个点突变(T51P),该类似物表现出近乎野生型的生物活性,但受体结合亲和力约低10倍。由于配体依赖性受体内化可能是控制IL-2受体信号传导持续时间的限速步骤,受体内化速率的降低可能有助于观察到的该类似物的反应增强。为了评估这种可能性,我们在三项独立的试验中比较了IL-2和T51P的内化情况。虽然IL-2的内化速率与其他人测定的值一致,但T51P的内化明显降低。该类似物的受体结合速率常数仅有轻微差异;因此,结合动力学的改变无法解释内化速率的降低。在生物测定中也可观察到内化减少的影响,与IL-2相比,T51P能使T细胞增殖维持更长时间。这些结果表明,与IL-2相比,T51P点突变以一种与解离速率无关的方式降低了受体内化速率。该类似物可能代表了一种制备具有增强激动剂和拮抗剂特性的细胞因子类似物的新方法。

相似文献

1
A point mutation in interleukin-2 that alters ligand internalization.白细胞介素-2中的一个点突变,该突变改变了配体内化。
J Biol Chem. 1996 Jun 7;271(23):13349-55. doi: 10.1074/jbc.271.23.13349.
2
Structural analogs of interleukin-2: a point mutation that facilitates biological response.白细胞介素-2的结构类似物:一种促进生物学反应的点突变。
Mol Pharmacol. 1995 Jan;47(1):206-11.
3
Receptor binding and internalization of mouse interleukin-2 derivatives that are partial agonists.作为部分激动剂的小鼠白细胞介素-2衍生物的受体结合与内化
J Biol Chem. 1992 Jul 5;267(19):13185-90.
4
DAB389 interleukin-2 receptor binding domain mutations. Cytotoxic probes for studies of ligand-receptor interactions.DAB389白细胞介素-2受体结合域突变。用于配体-受体相互作用研究的细胞毒性探针。
J Biol Chem. 1996 May 24;271(21):12145-9. doi: 10.1074/jbc.271.21.12145.
5
Mutagenic analysis of a receptor contact site on interleukin-2: preparation of an IL-2 analog with increased potency.白细胞介素-2受体接触位点的诱变分析:一种高效白细胞介素-2类似物的制备
Biochemistry. 1994 May 31;33(21):6571-7. doi: 10.1021/bi00187a026.
6
Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.用突变型白细胞介素-2类似物检测白细胞介素-2受体α亚基对高亲和力白细胞介素-2受体组装及功能的意外影响。
J Immunol. 1993 Apr 15;150(8 Pt 1):3357-65.
7
Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response.
Biotechnol Prog. 2000 Sep-Oct;16(5):905-16. doi: 10.1021/bp000097t.
8
Recombinant interleukin-2 analogs. Dynamic probes for receptor structure.重组白细胞介素-2类似物。受体结构的动态探针。
J Biol Chem. 1992 Sep 15;267(26):18511-9.
9
Structural and biologic properties of a human aspartic acid-126 interleukin-2 analog.人天冬氨酸-126白细胞介素-2类似物的结构和生物学特性
Arch Biochem Biophys. 1993 Dec;307(2):411-5. doi: 10.1006/abbi.1993.1608.
10
Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.白细胞介素(IL)-13受体高亲和力形式的动力学分析:IL-2受体γ链对IL-13结合的抑制作用
Biophys J. 1999 Jul;77(1):154-72. doi: 10.1016/S0006-3495(99)76879-7.

引用本文的文献

1
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024.T细胞生长因子白细胞介素-2偶尔会成为自身抗体的靶点,有资格作为治疗过敏、自身免疫和癌症的药物:国际变态反应学会(CIA)2024年更新。
Int Arch Allergy Immunol. 2024;185(3):286-300. doi: 10.1159/000533677. Epub 2023 Dec 12.
2
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity.IL-2 与 IL-2Rα 的临近效应共价结合,选择性地激活调节性 T 细胞并抑制自身免疫。
Signal Transduct Target Ther. 2023 Jan 23;8(1):28. doi: 10.1038/s41392-022-01208-3.
3
Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein.
使用包封在脂质中的编码长效 IL-2 突变体的 mRNA 选择性激活和扩增调节性 T 细胞。
Nat Commun. 2022 Jul 5;13(1):3866. doi: 10.1038/s41467-022-31130-9.
4
Insights into cytokine-receptor interactions from cytokine engineering.细胞因子工程对细胞因子-受体相互作用的见解。
Annu Rev Immunol. 2015;33:139-67. doi: 10.1146/annurev-immunol-032713-120211. Epub 2014 Dec 10.
5
Mechanistic model of natural killer cell proliferative response to IL-15 receptor stimulation.自然杀伤细胞对白细胞介素-15 受体刺激的增殖反应的机制模型。
PLoS Comput Biol. 2013;9(9):e1003222. doi: 10.1371/journal.pcbi.1003222. Epub 2013 Sep 12.
6
IL-15, in synergy with RAE-1ɛ, stimulates TCR-independent proliferation and activation of CD8(+) T cells.白细胞介素-15与RAE-1ɛ协同作用,刺激CD8(+) T细胞的非T细胞受体依赖性增殖和活化。
Oncol Lett. 2012 Feb;3(2):472-476. doi: 10.3892/ol.2011.495. Epub 2011 Nov 25.
7
Targeting activity of a TCR/IL-2 fusion protein against established tumors.靶向TCR/IL-2融合蛋白对已形成肿瘤的活性。
Cancer Immunol Immunother. 2008 Dec;57(12):1781-94. doi: 10.1007/s00262-008-0504-7. Epub 2008 Mar 28.
8
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.通过与可溶性白细胞介素-15受体α结合将白细胞介素-15转化为超激动剂。
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9166-71. doi: 10.1073/pnas.0600240103. Epub 2006 Jun 6.
9
Gamma chain receptor interleukins: evidence for positive selection driving the evolution of cell-to-cell communicators in the mammalian immune system.γ链受体白细胞介素:正向选择驱动哺乳动物免疫系统中细胞间通讯分子进化的证据。
J Mol Evol. 2005 Nov;61(5):608-19. doi: 10.1007/s00239-004-0313-3. Epub 2005 Oct 4.
10
Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.白细胞介素(IL)-13受体高亲和力形式的动力学分析:IL-2受体γ链对IL-13结合的抑制作用
Biophys J. 1999 Jul;77(1):154-72. doi: 10.1016/S0006-3495(99)76879-7.